Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
JERUSALEM, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company) is pleased to announce that it has received final results with respect to a clinical trial that...
-
JERUSALEM, Jan. 16, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") announced today that it has received a medical device license to market its Deep TMS system in...
-
JERUSALEM, Jan. 10, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") is proud to announce that the U.S. Food and Drug Administration ("FDA") has approved its...
-
JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to that stated in Brainsway's (TASE:BRIN) periodic report for 2011 regarding the double-blind clinical trial being conducted at the Charité...
-
JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to Brainsway's (TASE:BRIN) announcement regarding the association between Brainsway and Advanced Technologies Innovation Distribution SRL ("ATID")...
-
JERUSALEM, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the execution of an agreement for the marketing and distribution of its Deep TMS device in Nordic...
-
JERUSALEM, Aug. 21, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA) is pleased to announce that, further to its press release of November 1, 2011, the Company has contracted with 18 medical research...
-
JERUSALEM, July 24, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received approval from Israel's Ministry of Health to test the efficacy of its Deep TMS...
-
JERUSALEM, July 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to a clinical trial being conducted at the Sheba Medical...
-
JERUSALEM, July 2, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received CE Mark enabling commercialization of its Deep TMS system to treat neuropathic...